HIGHLIGHTS
- who: Huilin Xu and collaborators from the Department of Oncology, Te Fifth Hospital of Wuhan, Wuhan, Hubei, China Department of Oncology, RenMin Hospital of Wuhan University, Wuhan, Hubei, China have published the research work: Assessing Potential Factors Influencing the Efficacy of Immune Checkpoint Inhibitors with Radiation in Advanced Non-Small-Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis, in the Journal: Journal of Oncology of 13/01/2023
- what: The authors assessed the efcacy and safety of ICI plus radiation versus ICI alone and explored potential factors afecting its efcacy in advanced non . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.